Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Markus Ditschkowski"'
Autor:
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, Dietlinde Janson, Kerstin Schäfer-Eckart, Johannes Gärtner, Stephan Mielke, Martin Schreder, Guido Kobbe, Mustafa Kondakci, Inken Hilgendorf, Marie von Lilienfeld-Toal, Stefan Klein, Daniela Heidenreich, Sebastian Kreil, Mareike Verbeek, Sandra Grass, Markus Ditschkowski, Tanja Gromke, Martina Koch, Monika Lindemann, Thomas Hünig, Traudel Schmidt, Anne Rascle, Harald Guldan, Sascha Barabas, Ludwig Deml, Ralf Wagner, Daniel Wolff
Publikováno v:
Haematologica, Vol 106, Iss 2 (2019)
Recurrence of cytomegalovirus reactivation remains a major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Monitoring cytomegalovirus-specific cellular immunity using a standardized assay might improve t
Externí odkaz:
https://doaj.org/article/7480ee8f27644c2597b4e8a470fe521f
Autor:
Monika Lindemann, Vesna Klisanin, Laura Thümmler, Neslinur Fisenkci, Nikolaos Tsachakis-Mück, Markus Ditschkowski, Sina Schwarzkopf, Hannes Klump, Hans Christian Reinhardt, Peter A. Horn, Michael Koldehoff
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1075 (2021)
The cellular response to SARS-CoV-2 vaccination and infection in allogeneic hematopoietic stem cell transplant (HSCT) recipients is not yet clear. In the current study, HSCT recipients prior to and post vaccination were tested for SARS-CoV-2-specific
Externí odkaz:
https://doaj.org/article/172dde52a461444c83e6e9f9983f2a5d
Autor:
Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke, Kerstin Schäfer-Eckart, Johannes Gärtner, Stephan Mielke, Martin Schreder, Guido Kobbe, Inken Hilgendorf, Stefan Klein, Mareike Verbeek, Markus Ditschkowski, Martina Koch, Monika Lindemann, Traudel Schmidt, Anne Rascle, Sascha Barabas, Ludwig Deml, Ralf Wagner, Daniel Wolff
Publikováno v:
Diagnostics, Vol 11, Iss 2, p 312 (2021)
Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality following hematopoietic stem cell transplantation (HSCT). Measuring CMV-specific cellular immunity may improve the risk stratification and management of patients. IFN-γ ELIS
Externí odkaz:
https://doaj.org/article/277e39ca7f204dbc94a0e617167498ec
Autor:
Markus Ditschkowski, Ahmet H. Elmaagacli, Rudolf Trenschel, Tanja Gromke, Nina K. Steckel, Michael Koldehoff, Dietrich W. Beelen
Publikováno v:
Haematologica, Vol 97, Iss 10 (2012)
Background Myelofibrosis is a myeloproliferative stem cell disorder curable exclusively by allogeneic hematopoietic stem cell transplantation and is associated with substantial mortality and morbidity. The aim of this study was to assess disease-spec
Externí odkaz:
https://doaj.org/article/e5d5175cb3d3475c892f537004143bf3
Autor:
Markus Ditschkowski, Ahmet H. Elmaagacli, Rudolf Trenschel, Rudolf Peceny, Michael Koldehoff, Claudia Schulte, Dietrich W. Beelen
Publikováno v:
Haematologica, Vol 92, Iss 4 (2007)
Bronchiolitis obliterans (BO) and bronchiolitis obliterans organizing pneumonia (BOOP) are late-onset non-infectious pulmonary complications (LONIPCs) following allogeneic hematopoietic stem cell transplantation (HSCT). In the present study 10 of 197
Externí odkaz:
https://doaj.org/article/e8a98e7c24b549b68732ae6f0c14f56d
Publikováno v:
Transfusionsmedizin. 12:227-232
ZusammenfassungMit den hochsensitiven Methoden zur Chimärismusanalyse kann ein Rezidiv bedeutend früher prognostiziert werden. Für die Prognose ist hierbei vor allem die Dynamik des Anstiegs im Eigenanteil entscheidend, dies gilt auch schon für s
Autor:
Nicola Polverelli, Juan Carlos Hernández-Boluda, Tomasz Czerw, Tiziano Barbui, Mariella D'Adda, Hans Joachim Deeg, Markus Ditschkowski, Claire Harrison, Nicolaus Martin Kröger, Ruben Mesa, Francesco Passamonti, Francesca Palandri, Naveen Pemmaraju, Uday Popat, Damiano Rondelli, Alessandro Maria Vannucchi, Srdan Verstovsek, Marie Robin, Antonio Colecchia, Luigi Grazioli, Enrico Damiani, Domenico Russo, Jessica Brady, David Patch, Slawomir Blamek, Gandhi Laurent Damaj, Patrick Hayden, Donal P McLornan, Ibrahim Yakoub-Agha
Splenomegaly is a hallmark of myelofibrosis, a debilitating haematological malignancy for which the only curative option is allogeneic haematopoietic cell transplantation (HCT). Considerable splenic enlargement might be associated with a higher risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ae37a526a8f51a5ebebd0cb2294eed
https://hdl.handle.net/11379/569809
https://hdl.handle.net/11379/569809
Autor:
Julia Winkler, Andreas Mackensen, Jörg H W Distler, Clara Dees, Xianyi Meng, Andreas Beilhack, Wolfgang Herr, Honglin Zhu, Cuong Tran-Manh, Thuong Trinh-Minh, Katja Dreißigacker, Mirjana Ziemer, Yun Zhang, Bernd M. Spriewald, Chih-Wei Chen, Alexandru-Emil Matei, Sigrid Karrer, Daniel Wolff, Georg Schett, Lichong Shen, Markus Ditschkowski, Stefan Krauss
Publikováno v:
Blood. 137:2403-2416
Chronic graft-versus-host disease (cGVHD) is a major life-threatening complication of allogeneic hematopoietic stem cell transplantation. The molecular mechanisms underlying cGVHD remain poorly understood, and targeted therapies for clinical use are
Autor:
Nico Gagelmann, Christine Wolschke, Rachel B. Salit, Thomas Schroeder, Markus Ditschkowski, Victoria Panagiota, Bruno Cassinat, Felicitas Thol, Anita Badbaran, Marie Robin, Hans Christian Reinhardt, Francis Ayuk, Michael Heuser, Bart L. Scott, Nicolaus Kröger
Publikováno v:
Blood advances. 6(4)
Accelerated-phase myelofibrosis, currently defined by circulating blasts 10% to 19%, usually confers very high risk for progression and poor outcome. The outcome of hematopoietic stem cell transplantation for accelerated-phase myelofibrosis has not b
Autor:
Nikolaos Tsachakis-Mück, Sina Schwarzkopf, Laura Thümmler, Neslinur Fisenkci, Monika Lindemann, Peter A. Horn, Hannes Klump, Markus Ditschkowski, Hans Christian Reinhardt, Michael Koldehoff, Vesna Klisanin
Publikováno v:
Vaccines, Vol 9, Iss 1075, p 1075 (2021)
Vaccines
Volume 9
Issue 10
Vaccines
Volume 9
Issue 10
The cellular response to SARS-CoV-2 vaccination and infection in allogeneic hematopoietic stem cell transplant (HSCT) recipients is not yet clear. In the current study, HSCT recipients prior to and post vaccination were tested for SARS-CoV-2-specific